BOLTON SECURITIES CORPORATION’s Cellebrite CLBT Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$135K	Buy	+12,000	New	+$160K	0.01%	1027

Other funds holding CLBT

True Wind Capital Management San Francisco, California $156M AUM 31.3% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Central Securities New York $1.39B AUM 16.6% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's CLBT Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Cellebrite (CLBT) in Q3 2026: 12,000 shares worth $135K. The stake represents 0.01% of the portfolio and ranks #1027 among its holdings.

102 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

BOLTON SECURITIES CORPORATION held 12,000 shares of Cellebrite worth $135K as of Q3 2026.
Cellebrite was a new BOLTON SECURITIES CORPORATION position in Q3 2026.
Cellebrite made up 0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1027 holding.
102 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.